Actinomycosis
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
non-penicillin allergic
penicillin or amoxicillin
Prolonged high-dose antibiotic therapy with a penicillin is the preferred treatment. Given parenterally for 4 to 6 weeks, followed by oral therapy for a further 3 to 6 months. Parenteral therapy can be given on an inpatient or outpatient basis, depending on severity of disease.[1]Smego RA Jr, Foglia G. Actinomycosis. Clin Infect Dis. 1998 Jun;26(6):1255-61. http://www.ncbi.nlm.nih.gov/pubmed/9636842?tool=bestpractice.com [11]Russo T. Actinomycosis. In: Kasper DL, Fauci AS, Longo DL, et al, eds. Harrison's principles of internal medicine. 16th ed. New York, NY: McGraw-Hill; 2005:937-9.[51]Sudhakar SS, Ross JJ. Short-term treatment of actinomycosis: two cases and a review. Clin Infect Dis. 2004 Feb 1;38(3):444-7. http://cid.oxfordjournals.org/content/38/3/444.long http://www.ncbi.nlm.nih.gov/pubmed/14727221?tool=bestpractice.com [59]Japanese Society of Chemotherapy Committee on Guidelines for Treatment of Anaerobic Infections; Japanese Association for Anaerobic Infection Research. Chapter 2-12-1. Anaerobic infections (individual fields): actinomycosis. J Infect Chemother. 2011 Jul;17(suppl 1):119-20. http://www.ncbi.nlm.nih.gov/pubmed/21728107?tool=bestpractice.com Consultation with an expert in microbiology or infectious diseases is recommended.[7]Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ. 2011 Oct 11;343:d6099. http://www.ncbi.nlm.nih.gov/pubmed/21990282?tool=bestpractice.com
Primary options
penicillin G potassium: 10-20 million units/day intravenously/intramuscularly given in divided doses every 4-6 hours for 4-6 weeks
and
penicillin V potassium: 2-4 g/day orally given in 4-6 divided doses for 3-6 months after cessation of intravenous therapy
OR
ampicillin: 50 mg/kg/day intravenously given in divided doses every 8 hours for 4-6 weeks
and
amoxicillin: 500 mg orally three times daily for 3-6 months after cessation of intravenous therapy
intrauterine device removal
Treatment recommended for SOME patients in selected patient group
Intrauterine devices should be removed from patients with pelvic or abdominal actinomycosis.[7]Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ. 2011 Oct 11;343:d6099. http://www.ncbi.nlm.nih.gov/pubmed/21990282?tool=bestpractice.com [57]Bonacho I, Pita S, Gómez-Besteiro MI. The importance of the removal of the intrauterine device in genital colonization by actinomyces. Gynecol Obstet Invest. 2001;52(2):119-23. http://www.ncbi.nlm.nih.gov/pubmed/11586040?tool=bestpractice.com
surgical excision of lesions
Treatment recommended for ALL patients in selected patient group
These patients may require surgery to excise the lesions in addition to antibiotics.[58]Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope. 1984 Sep;94(9):1198-217. http://www.ncbi.nlm.nih.gov/pubmed/6381942?tool=bestpractice.com
penicillin allergic
non-penicillin antibiotics
Ceftriaxone, clindamycin, erythromycin, or doxycycline can be used. Therapy needs to be given for several months. Most regimens involve an initial period of parenteral therapy, which can be given on an inpatient or outpatient basis, depending on severity of disease.[48]Wagenlehner FM, Mohren B, Naber KG, et al. Abdominal actinomycosis. Clin Microbiol Infect. 2003 Aug;9(8):881-5. http://onlinelibrary.wiley.com/doi/10.1046/j.1469-0691.2003.00653.x/full http://www.ncbi.nlm.nih.gov/pubmed/14616714?tool=bestpractice.com [53]Martin MV. Antibiotic treatment of cervicofacial actinomycosis for patients allergic to penicillin: a clinical and in vitro study. Br J Oral Maxillofac Surg. 1985 Dec;23(6):428-34. http://www.ncbi.nlm.nih.gov/pubmed/2933063?tool=bestpractice.com [54]Leafstedt SW, Gleeson RM. Cervicofacial actinomycosis. Am J Surg. 1975 Oct;130(4):496-8. http://www.ncbi.nlm.nih.gov/pubmed/1166943?tool=bestpractice.com [55]Makaryus AN, Latzman J, Yang R, et al. A rare case of Actinomyces israelii presenting as pericarditis in a 75-year-old man. Cardiol Rev. 2005 May-Jun;13(3):125-7. http://www.ncbi.nlm.nih.gov/pubmed/15831144?tool=bestpractice.com [56]Brown R, Bancewicz J. Ureteric obstruction due to pelvic actinomycosis. Br J Surg. 1982 Mar;69(3):156. http://www.ncbi.nlm.nih.gov/pubmed/7066656?tool=bestpractice.com
Patients with mild cervicofacial actinomycosis of endodontic origin may be given oral doxycycline from the outset. Consultation with an expert in microbiology or infectious diseases is recommended.[7]Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ. 2011 Oct 11;343:d6099. http://www.ncbi.nlm.nih.gov/pubmed/21990282?tool=bestpractice.com
Primary options
ceftriaxone: 2 g intravenously/intramuscularly every 12-24 hours for 4-6 weeks
and
doxycycline: 100 mg orally twice daily for 3-6 months after cessation of intravenous therapy
OR
erythromycin lactobionate: 500 mg intravenously every 6 hours for 4-6 weeks
and
erythromycin base: 500 mg orally twice daily for 3-6 months after cessation of intravenous therapy
OR
doxycycline: 100 mg twice daily orally for 4-6 months
intrauterine device removal
Treatment recommended for SOME patients in selected patient group
Intrauterine devices should be removed from patients with pelvic or abdominal actinomycosis.[7]Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ. 2011 Oct 11;343:d6099. http://www.ncbi.nlm.nih.gov/pubmed/21990282?tool=bestpractice.com [57]Bonacho I, Pita S, Gómez-Besteiro MI. The importance of the removal of the intrauterine device in genital colonization by actinomyces. Gynecol Obstet Invest. 2001;52(2):119-23. http://www.ncbi.nlm.nih.gov/pubmed/11586040?tool=bestpractice.com
surgical excision of lesions
Treatment recommended for ALL patients in selected patient group
These patients may require surgery to excise the lesions in addition to antibiotics.[58]Bennhoff DF. Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases. Laryngoscope. 1984 Sep;94(9):1198-217. http://www.ncbi.nlm.nih.gov/pubmed/6381942?tool=bestpractice.com
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer